Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and HCA Healthcare (HCA)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alcon (ALC) and HCA Healthcare (HCA).
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alcon (ALC)
RBC Capital analyst Jack Reynolds-Clark maintained a Buy rating on Alcon today. The company’s shares closed last Tuesday at $74.05.
According to TipRanks.com, Reynolds-Clark is ranked #5950 out of 12128 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alcon with a $95.13 average price target, representing a 28.3% upside. In a report issued on March 19, TipRanks – xAI also upgraded the stock to Buy with a CHF67.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
HCA Healthcare (HCA)
In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on HCA Healthcare, with a price target of $541.00. The company’s shares closed last Tuesday at $466.52.
According to TipRanks.com, Breen is a 4-star analyst with an average return of
HCA Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $551.50.
Read More on ALC:
Disclaimer & DisclosureReport an Issue
- Sight Sciences awarded monetary damages by district court against Alcon
- Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates
- Lensar upgraded to Buy from Neutral at BTIG
- Lensar down 23% following termination of merger agreement with Alcon
- Alcon, Lensar agree to terminate merger agreement
